Utang jangka cendhak marang modal: Quidel Corporation (QDEL)

Tandha merek QuidelOrtho (QDEL)

The linear price action on the GURU.Markets platform chart for QuidelOrtho (QDEL), which has a debt ratio of 0.22, demonstrates the position of this diagnostics giant. The business relies on a global network of instruments, generating profit from the sale of consumables. Development is focused on device compactness and the robotization of tests. Success is driven by leading biochemists, attracted by substantial funding for scientific research and noble goals.

QDEL - Utang jangka cendhak marang modal QuidelOrtho Corp ing rentang 04.07.2022 - 29.10.2026
Produk merek QuidelOrtho Corporation

For the long-term investor, the reliability of QuidelOrtho (QDEL) currently depends on its ability to service obligations amid falling demand for rapid tests and rising unit costs. The ratio of loans under one year to equity, reflected in this short-term liabilities-to-equity chart, measures the risk of liquidity loss, confirming the stability of the company's financial structure during the restructuring of its operating leverage.

Pesaing QuidelOrtho (QDEL)

Utang jangka cendhak marang modal A|DGX - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang modal ILMN (Illumina, Inc.)|EXAS: Rasio utang jangka cendhak marang modal|Revvity - Utang jangka cendhak marang modal|BIO - Utang jangka cendhak marang modal|Anbio Tech (NNNN) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang modal SHC|OPK (OPKO Health, Inc.) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal CareDx Corp|Utang jangka cendhak marang ekuitas Maravai LifeSciences Holdings, Inc. (MRVI)|Utang jangka cendhak marang ekuitas FLGT (Fulgent Genetics Inc)|Fluidigm - Rasio utang jangka cendhak marang ekuitas|Cytek Corp (CTKB) - Kewajiban jangka cendhak marang modal|OSUR - Utang jangka cendhak marang ekuitas|Koefisien utang jangka cendhak marang modal Exagen Inc. XGN|MDXH: Utang jangka cendhak marang modal|LUCD - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Prenetics Global Limited|Insight Molecular (IMDX) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Trinity Biotech plc (TRIB)|prophaselabs.com (PRPH) - Tanggungan utang jangka cendhak marang ekuitas|Ainos - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal Co-Diagnostics Inc CODX|Heart Test Laboratories Inc. - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal Biomerica Inc BMRA|CDIO: Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang modal VRAX|BJDX (Bluejay Diagnostics, Inc.) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Aspira Women's Health, Inc. AWH|Utang jangka cendhak marang ekuitas Accelerate Diagnostics, Inc (AXDX)|Utang jangka cendhak marang ekuitas CNTG (Centogene)|Utang jangka cendhak marang ekuitas Enzo Biochem ENZ|Fresh2 Group Ltd (FRES) - Kewajiban jangka cendhak marang modal|GENE - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal ME (23andMe Holding Co)|PMD (Psychemedics Corp) - Rasio utang jangka cendhak marang ekuitas